Fig. 4: ITGB4 downregulation is related to a lower proliferation of glioma cells and better prognosis for glioma patients. | Cell Death Discovery

Fig. 4: ITGB4 downregulation is related to a lower proliferation of glioma cells and better prognosis for glioma patients.

From: IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT

Fig. 4

A ITGB4 protein expression in Itgb4 siRNA-transfected cells. B Cell proliferation was measured by Trypan blue staining. C Same number of ITGB4 siRNA-transfected and siNC-transfected cells were treated with D-2HG for 48 h. Cell viability was measured by CCK-8 assay. D Total cell count, E Live cell counts, F Dead cell counts were measured by Trypan blue staining. G ITGB4 protein expression in ITGB4-overexpressed cells. H ITGB4-overexpressed enhances the proliferation of glioma cells while simultaneously weakening the anti-tumor effect of D-2HG. I–L The relationship between ITGB4 expression and IDH1 mutation, the numbers in brackets represent the number of cases. M–P The relationship between ITGB4 expression and the prognosis of glioma patients.

Back to article page